Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma

The chromosomal translocation specifically linked to the Ewing sarcoma family results in the generation of fusion proteins comprising the amino terminal portion of EWS and the DNA-binding domain of ets transcription factors. The EWS/ets chimeric proteins act as aberrant transcription factors leading to tumorigenic processes. We searched for genes specifically activated in Ewing sarcoma cells but not in other tumor cell lines using the gene array technique, and found significantly enhanced expression of the Id2 gene. High levels of Id2 transcripts were detected in Ewing sarcoma cell lines and tumor tissues. The EWS/ets chimeric proteins activated the Id2 gene via the 5′-upstream promoter sequence. Chromatin-immunoprecipitation revealed a direct interaction of EWS/Fli-1 with the promoter regions of the Id2, TGF-β type II receptor, cyclin D1, and c-myc genes. Since EWS/Fli-1 transactivates c-myc, a cooperative action of the chimeric protein and c-myc leads to overexpression of Id2. In the present study, we suggest that Id2 is a target of the chimeric proteins and that the c-myc/Id2 pathway plays a pivotal role in the tumorigenic processes provoked by EWS/ets proteins.

[1]  W. Winkelmann,et al.  Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Seth,et al.  ETS family proteins activate transcription from HIV-1 long terminal repeat. , 1993, AIDS research and human retroviruses.

[3]  Harold Weintraub,et al.  The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.

[4]  O. Delattre,et al.  Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2 and c-Myc expression , 2001, Oncogene.

[5]  A. Iavarone,et al.  Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins , 2000, Nature.

[6]  M. Bronner‐Fraser,et al.  Neural crest specification regulated by the helix-loop-helix repressor Id2. , 1998, Science.

[7]  P. Gruss,et al.  Neuronal expression of regulatory helix-loop-helix factor Id2 gene in mouse. , 1993, Developmental biology.

[8]  G M Edelman,et al.  Synthetic promoter elements obtained by nucleotide sequence variation and selection for activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. M. Boss,et al.  CREB regulates MHC class II expression in a CIITA-dependent manner. , 1999, Immunity.

[10]  Erica A Golemis,et al.  Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II , 1998, Oncogene.

[11]  R. Tantravahi,et al.  Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[13]  M. Roussel,et al.  DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma , 1994, Molecular and cellular biology.

[14]  G. Thomas,et al.  A new member of the ETS family fused to EWS in Ewing tumors , 1997, Oncogene.

[15]  B. Wasylyk,et al.  The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation , 1990, Nature.

[16]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[17]  J. Hata,et al.  Neurogenic potential of Ewing's sarcoma cells , 2005, Virchows Archiv.

[18]  J. Hata,et al.  A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. , 1996, Biochemical and biophysical research communications.

[19]  Ahmed Mansouri,et al.  Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2 , 1999, Nature.

[20]  B. Erman,et al.  Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins. , 1993, Science.